Teva Pharmaceutical Industries (TEVA) News Today $18.34 +0.30 (+1.64%) As of 01:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TEVA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Teva Pharmaceutical Industries Limited (TEVA) Gains FDA Nod for Pediatric Migraine Drug AJOVY4 hours ago | finance.yahoo.comAPG Asset Management N.V. Decreases Stock Position in Teva Pharmaceutical Industries Ltd. $TEVAAugust 29 at 5:06 AM | marketbeat.comAnalysts Set Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Target Price at $24.71August 29 at 2:35 AM | americanbankingnews.comTeva stock rises on launch of first generic weight loss GLP-1 drugAugust 28 at 11:10 AM | in.investing.comTEVA Trumpets Saxenda, Stocks Eke HigherAugust 28 at 11:10 AM | baystreet.caTeva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight LossAugust 28 at 11:10 AM | finance.yahoo.comUS FDA approves Teva Pharmaceuticals' generic obesity drugAugust 28 at 9:17 AM | reuters.comRaymond James Financial Inc. Decreases Stake in Teva Pharmaceutical Industries Ltd. $TEVAAugust 28 at 4:00 AM | marketbeat.comTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives Consensus Recommendation of "Buy" from AnalystsAugust 28 at 3:26 AM | marketbeat.comTeva's Pivot To (Innovative) Growth: Re-Rating Should ContinueAugust 28 at 2:01 AM | seekingalpha.comHow Investors May Respond To ACADIA Pharmaceuticals (ACAD) Hiring an Industry Veteran for Growth StrategyAugust 27 at 8:09 AM | finance.yahoo.comQuantbot Technologies LP Has $703,000 Holdings in Teva Pharmaceutical Industries Ltd. $TEVAAugust 27 at 4:12 AM | marketbeat.comBI Asset Management Fondsmaeglerselskab A S Has $653,000 Stock Position in Teva Pharmaceutical Industries Ltd. $TEVAAugust 26 at 4:24 AM | marketbeat.comPiper Sandler Reiterates a Buy Rating on Teva Pharmaceutical Industries (TEVA)August 25, 2025 | insidermonkey.comPiper Sandler Reiterates a Buy Rating on Teva Pharmaceutical Industries (TEVA)August 25, 2025 | finance.yahoo.comJump Financial LLC Has $20.37 Million Position in Teva Pharmaceutical Industries Ltd. $TEVAAugust 25, 2025 | marketbeat.comRussell Investments Group Ltd. Buys 61,330 Shares of Teva Pharmaceutical Industries Ltd. $TEVAAugust 25, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Buys 296,012 Shares of Teva Pharmaceutical Industries Ltd. $TEVAAugust 24, 2025 | marketbeat.comAtika Capital Management LLC Invests $6.72 Million in Teva Pharmaceutical Industries Ltd. $TEVAAugust 23, 2025 | marketbeat.comTeva Pharmaceutical: Tariff Relief Clears The Way For ReinventionAugust 22, 2025 | seekingalpha.comBanco BTG Pactual S.A. Has $571,000 Position in Teva Pharmaceutical Industries Ltd. $TEVAAugust 22, 2025 | marketbeat.comNorthwest & Ethical Investments L.P. Has $548,000 Stock Position in Teva Pharmaceutical Industries Ltd. $TEVAAugust 22, 2025 | marketbeat.comAberdeen Group plc Acquires 286,206 Shares of Teva Pharmaceutical Industries Ltd. $TEVAAugust 21, 2025 | marketbeat.comState of New Jersey Common Pension Fund D Buys 41,300 Shares of Teva Pharmaceutical Industries Ltd. $TEVAAugust 20, 2025 | marketbeat.comBillionaire Stanley Druckenmiller Sold All of His Palantir and Has Piled Into This High-Flying Drug Stock for 4 Consecutive QuartersAugust 20, 2025 | fool.comFjarde AP Fonden Fourth Swedish National Pension Fund Has $4.49 Million Stock Holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)August 19, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd. $TEVA Shares Sold by National Bank of Canada FIAugust 19, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Holdings Lifted by Menora Mivtachim Holdings LTD.August 18, 2025 | marketbeat.comNational Pension Service Has $25.44 Million Stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)August 18, 2025 | marketbeat.comResona Asset Management Co. Ltd. Boosts Stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)August 18, 2025 | marketbeat.comNuveen LLC Takes Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)August 18, 2025 | marketbeat.comInvesco Ltd. Sells 1,377,277 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)August 18, 2025 | marketbeat.comTejara Capital Ltd Makes New $2.78 Million Investment in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)August 17, 2025 | marketbeat.comLord Abbett & CO. LLC Boosts Stock Holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)August 17, 2025 | marketbeat.comPublic Sector Pension Investment Board Has $9.03 Million Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)August 16, 2025 | marketbeat.comVirtu Financial LLC Buys Shares of 24,154 Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)August 16, 2025 | marketbeat.comDeutsche Bank AG Boosts Stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)August 14, 2025 | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Acquires 53,443 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)August 13, 2025 | marketbeat.comTeva Pharmaceutical continues gains for seven straight sessionsAugust 12, 2025 | msn.comTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Acquired by Todd Asset Management LLCAugust 12, 2025 | marketbeat.com30,900 Shares in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Purchased by ASR Vermogensbeheer N.V.August 11, 2025 | marketbeat.comHeadlands Technologies LLC Has $486,000 Stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)August 10, 2025 | marketbeat.comKeystone Investors PTE Ltd. Acquires Shares of 45,432 Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)August 9, 2025 | marketbeat.comiA Global Asset Management Inc. Reduces Stock Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)August 7, 2025 | marketbeat.comTeva’s Ajovy becomes first migraine prevention drug approved for childrenAugust 6, 2025 | finance.yahoo.comTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Insider Sells $91,763.48 in StockAugust 6, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Insider Eric A. Hughes Sells 52,742 SharesAugust 6, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd. (NYSE:TEVA) Insider Sells $91,763.48 in StockAugust 6, 2025 | insidertrades.comNatixis Advisors LLC Has $5.12 Million Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)August 6, 2025 | marketbeat.comUS FDA approves Teva's Ajovy for migraine prevention in childrenAugust 5, 2025 | reuters.com Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TEVA Media Mentions By Week TEVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEVA News Sentiment▼1.271.03▲Average Medical News Sentiment TEVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEVA Articles This Week▼2016▲TEVA Articles Average Week Get the Latest News and Ratings for TEVA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Teva Pharmaceutical Industries and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies GSK News TAK News ARGX News ONC News INSM News BNTX News SMMT News GMAB News VTRS News RDY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TEVA) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access